awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q41145898-4D53CBA9-A1B5-446C-96FE-3380793C5886
Q41145898-4D53CBA9-A1B5-446C-96FE-3380793C5886
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41145898-4D53CBA9-A1B5-446C-96FE-3380793C5886
Progression-free survival of first-line treatment with molecular-targeted therapy may be a meaningful intermediate endpoint for overall survival in patients with metastatic renal cell carcinoma.
P2860
Q41145898-4D53CBA9-A1B5-446C-96FE-3380793C5886
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41145898-4D53CBA9-A1B5-446C-96FE-3380793C5886
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2a5cd4f3a041607d793046592227fd3d5bfba7b3
P2860
Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial